Week 3 - Big Fish Eat Little Fish - is M&A the ‘22 Biotech Bailout?
Macro Continues to Push Risk Down…
Hello Avatar! Welcome back for another week of biotech analysis. Not too much significant news flow to drive the market in either direction. The market free fall continues with not much of an end in sight as macro issues continue to put pressure on risk.
As a reminder, the purpose of the BowTiedBiotech substack is two-fold. Primarily, we aim to provi…
Keep reading with a 7-day free trial
Subscribe to BowTiedBiotech to keep reading this post and get 7 days of free access to the full post archives.